MITIM IS PART OF RECIPHARM

On 24th February 2016 Recipharm finalized the acquisition of Mitim S.r.l. Recipharm is a global pharmaceutical Contract Development and Manufacturing Organanisation (CDMO) in the pharmaceutical industry based in Sweden and listed on Nasdaq OMX Stockholm.

You will be redirected to www.recipharm.com in 10 seconds.